Search

for
Search:

Sort by

Research

270-300 / 1000+ results

research Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research

123 citations , December 2015 in “Journal of Neuroendocrinology”

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Midazolam Ameliorates the Behavioral Deficits of a Rat Posttraumatic Stress Disorder Model Through Dual 18 kDa Translocator Protein and Central Benzodiazepine Receptor and Neurosteroidogenesis

research Midazolam Ameliorates the Behavior Deficits of a Rat Posttraumatic Stress Disorder Model through Dual 18 kDa Translocator Protein and Central Benzodiazepine Receptor and Neurosteroidogenesis

56 citations , July 2014 in “PLoS ONE”

Midazolam reduces PTSD-like behavior in rats by acting on specific brain receptors.

research Endophytes in Southeast Asia and Japan: their taxonomic diversity and potential applications

48 citations , January 2003

Endophytes from Southeast Asia and Japan can produce useful substances like enzymes and antibiotics.

research New steps forward in the neuroactive steroid field

31 citations , March 2015 in “The Journal of Steroid Biochemistry and Molecular Biology”

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

research Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens

14 citations , October 2016 in “Psychoneuroendocrinology”

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Demethylation of ITGAV Accelerates Osteogenic Differentiation in a Blast-Induced Heterotopic Ossification In Vitro Cell Culture Model

research Demethylation of ITGAV accelerates osteogenic differentiation in a blast-induced heterotopic ossification in vitro cell culture model

11 citations , December 2018 in “Bone”

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Stem Cell Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies

research Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies

9 citations , March 2011 in “Current Pharmaceutical Biotechnology”

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

research Reclassification of Botryococcus braunii chemical races into separate species based on a comparative genomics analysis

8 citations , July 2024 in “PLoS ONE”

Botryococcus braunii's three chemical races should be reclassified as separate species.

Antidepressant-Like Effect of Fluoxetine May Depend on Translocator Protein Activity and Pretest Session Duration in Forced Swimming Test in Mice

research Antidepressant-like effect of fluoxetine may depend on translocator protein activity and pretest session duration in forced swimming test in mice

7 citations , October 2017 in “Behavioural Pharmacology”

Fluoxetine's effectiveness as an antidepressant in mice depends on a specific protein activity and a 5-minute pretest.

research TSPO ligand etifoxine attenuates LPS-induced cognitive dysfunction in mice

5 citations , October 2020 in “Brain Research Bulletin”

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

research Cytoprotective effects of paeoniflorin are associated with translocator protein 18 kDa

3 citations , July 2018 in “Biomedicine & pharmacotherapy”

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

research Hair loss after covid 19 - case series

January 2023 in “Book of Abstracts”

The study investigated hair loss in 25 patients following COVID-19 infection, identifying various types of alopecia, with telogen effluvium (TE) being the most common. Five patients experienced acute TE, with hair loss starting a median of 2 months post-infection and lasting a median of 4 months. Fifteen patients had chronic TE, beginning a median of 6 months post-infection and lasting a median of 9 months. Additionally, five patients developed patchy alopecia areata (AA) 2-3 weeks after infection, with hair loss lasting a median of 10 months. The study highlighted that post-COVID hair loss could manifest in different alopecia types, with TE being the most prevalent.